PULMOKINE, INC.

Basic Information

PULMOKINE, INC.
68 QUEEN ANNE DR
SLINGERLANDS, NY, 12159-9385

http://www.pulmokine.net

Company Profile

n/a

Additional Details

Field Value
DUNS: 808479906
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension

    Amount: $1,004,898.00

    DESCRIPTION provided by applicant The purpose of this Phase II project is to develop a new treatment for pulmonary arterial hypertension PAH consisting of the inhaled platelet derived growth fact ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs

    Amount: $224,960.00

    Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ). PUBLIC H ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hyper

    Amount: $2,267,504.00

    DESCRIPTION (provided by applicant): The purpose of this Phase II project is to develop a new treatment for pulmonary arterial hypertension (PAH) consisting of the inhaled platelet derived growth fact ...

    SBIR Phase II 2012 Department of Health and Human Services
  4. A novel JAK inhibitor for the treatment of pulmonary arterial hypertension

    Amount: $311,629.00

    DESCRIPTION (provided by applicant): Pulmonary arterial hypertension (PAH) is a rare disease associated with high morbidity and mortality. The purpose of this proposal is to develop a novel combined J ...

    SBIR Phase I 2010 Department of Health and Human Services
  5. A PDGFR inhibitor for the treatment of pulmonary arterial hypertension

    Amount: $351,008.00

    DESCRIPTION (provided by applicant): Pulmonary arterial hypertension (PAH) is a devastating disease associated with high morbidity and mortality. The purpose of this proposal is to develop a novel hig ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government